Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q
Source: 0001731122-25-000258
Chunk: 2

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
     131,977,144 

    TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 
    $111,340,272  
    $163,129,450 

See accompanying notes to the unaudited condensed
consolidated financial statements.

2

RENOVARO INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

    For the Three Months Ended 
    For the Six Months Ended

    December 31, 
    December 31,

    2024 
    2023 
    2024 
    2023

    Operating Expenses 

    General and administrative 
    $4,353,123  
    $3,616,392  
    $9,654,373  
    $11,906,602 
  
    Research and development 
     161,084  
     620,521  
     551,273  
     1,187,165 
  
    Goodwill impairment 
     —  
     —  
     47,614,729  
     — 
  
    Depreciation and amortization 
     32,109  
     33,162  
     64,494  
     60,422 
  
    Total Operating Expenses 
     4,546,316  
     4,270,075  
     57,884,869  
     13,154,189 

    LOSS FROM OPERATIONS 
     (4,546,316) 
     (4,270,075) 
     (57,884,869) 
     (13,154,189)

    Other Income (Expenses) 

    Change in fair value of contingent consideration 
     (2,590,000) 
     —  
     6,660,000  
     — 
  
    Loss on extinguishment of debt 
     —  
     —  
     —  
     (120,018)
  
    Interest expense 
     (98,891) 
     (274,984) 
     (348,971) 
     (454,255)
  
    Interest and other income 
     (17,187) 
     15,938  
     109,411  
     24